Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: LBR Regulatory and Clinical Consulting Services, Inc.
February 3, 2026
LBR Regulatory and Clinical Consulting Services, Inc.
Orphan Drug Designation
treatment of tuberous sclerosis complex
Disease Area:
Rare Disease
Source
Source
Scroll to Top
